PETS FY 2020 Earnings Report — PetMed Express, Inc. Revenue & Financial Results | Market Cap Arena

PetMed Express, Inc.PETS

FY 2020 Earnings

Reported May 26, 2020

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2020	Prior Q	FY 2019	QoQ Change	YoY Change
Revenue	$284M	—	$283M	—	0.2%
Op. Income	$31M	—	$46M	—	-32.9%
Gross Margin	28.6%	—	33.6%	—	-5.0pp
Net Margin	9.1%	—	13.3%	—	-4.2pp
EPS (Diluted)	$1.29	—	$1.84	—	-29.9%
Free Cash Flow	$37M	—	$45M	—	-17.9%

Revenue Flow

Item	Amount
REVENUE	$284M
Cost of Revenue	$203M
GROSS PROFIT	$81M
R&D Expenses	$0
Selling & Marketing	$23M
General & Administrative	$25M
SG&A Expenses	$48M
Other Expenses	$2M
Operating Expenses	$50M
Cost & Expenses	$253M
OPERATING INCOME	$31M
Interest Income	$2M
Interest Expense	$0
Other Income/Expenses	$3M
INCOME BEFORE TAX	$34M
Income Tax Expense	$8M
Net Income from Continuing Ops	$26M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$26M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$26M
D&A	$2M
EBIT	$34M
EBITDA	$36M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$284M
Cost of Revenue	$203M
GROSS PROFIT	$81M
R&D Expenses	$0
Selling & Marketing	$23M
General & Administrative	$25M
SG&A Expenses	$48M
Other Expenses	$2M
Operating Expenses	$50M
Cost & Expenses	$253M
OPERATING INCOME	$31M
Interest Income	$2M
Interest Expense	$0
Other Income/Expenses	$3M
INCOME BEFORE TAX	$34M
Income Tax Expense	$8M
Net Income from Continuing Ops	$26M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$26M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$26M
D&A	$2M
EBIT	$34M
EBITDA	$36M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$26M
Depreciation & Amortization	$2M
Stock-Based Compensation	$3M
Deferred Income Tax	-$151.0K
Other Non-Cash Items	$191.0K
Change in Working Capital	$8M
OPERATING CASH FLOW	$39M
Capital Expenditure	-$2M
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$0
NET CASH FROM INVESTING	-$2M
Net Debt Issuance	$0
Common Stock Repurchased	-$11M
Common Dividends Paid	-$22M
Other Financing Activities	$0
NET CASH FROM FINANCING	-$33M
FREE CASH FLOW	$37M
Net Change in Cash	$3M

Balance Sheet

Item	Amount
Cash & Equivalents	$104M
Short-Term Investments	$0
Net Receivables	$4M
Inventory	$18M
Other Current Assets	$4M
TOTAL CURRENT ASSETS	$129M
PP&E (Net)	$25M
Goodwill	$0
Intangible Assets	$860.0K
Long-Term Investments	$26M
Tax Assets	$780.0K
Other Non-Current Assets	-$26M
TOTAL NON-CURRENT ASSETS	$26M
TOTAL ASSETS	$155M
Account Payables	$20M
Short-Term Debt	$0
Deferred Revenue	$0
Other Current Liabilities	$2M
TOTAL CURRENT LIABILITIES	$24M
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$970.0K
Other Non-Current Liabilities	$0
TOTAL NON-CURRENT LIABILITIES	$970.0K
TOTAL LIABILITIES	$25M
Common Stock	$20.0K
Additional Paid-In Capital	$4M
Retained Earnings	$126M
Treasury Stock	$0
Accum. Other Comp. Income	$0
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$130M
Minority Interest	$0
TOTAL EQUITY	$130M
TOTAL LIABILITIES & EQUITY	$155M
Total Debt	$0
Net Debt	-$104M